EARLY RECOGNITION OF IMMUNE CHECKPOINT MEDIATED MYOCARDITIS IN METASTATIC MELANOMA

被引:0
|
作者
Tavares, Matthew [1 ]
Otuonye, Gene [1 ]
Ayyagari, Lakshmi [1 ]
Chokshi, Aalap Dilip [1 ]
机构
[1] Hackensack Meridian Hlth Englewood Univ Med Ctr, Englewood, NJ USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1175-311
引用
收藏
页码:2577 / 2577
页数:1
相关论文
共 50 条
  • [31] Immune checkpoint inhibitors in advanced or metastatic mucosal melanoma: a systematic review
    Li, Jiarui
    Kan, Haoxuan
    Zhao, Lin
    Sun, Zhao
    Bai, Chunmei
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [32] Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma
    Teresa Kim
    Rodabe N.Amaria
    Christine Spencer
    Alexandre Reuben
    Zachary A.Cooper
    Jennifer A.Wargo
    Cancer Biology & Medicine, 2014, (04) : 237 - 246
  • [33] Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma
    Auslander, Noam
    Zhang, Gao
    Lee, Joo Sang
    Frederick, Dennie T.
    Miao, Benchun
    Moll, Tabea
    Tian, Tian
    Wei, Zhi
    Madan, Sanna
    Sullivan, Ryan J.
    Boland, Genevieve
    Flaherty, Keith
    Herlyn, Meenhard
    Ruppin, Eytan
    NATURE MEDICINE, 2018, 24 (10) : 1545 - +
  • [34] Peripheral blood biomarkers in immune checkpoint inhibition therapy in metastatic melanoma
    Ghelani, Ghanshyam H.
    Mandava, Anupa
    Zerdan, Maroun Bou
    Mehta, Radhika
    Sivapiragasam, Abirami
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [35] Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma
    Teresa Kim
    Rodabe NAmaria
    Christine Spencer
    Alexandre Reuben
    Zachary ACooper
    Jennifer AWargo
    Cancer Biology & Medicine, 2014, 11 (04) : 237 - 246+213
  • [36] Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma
    Noam Auslander
    Gao Zhang
    Joo Sang Lee
    Dennie T. Frederick
    Benchun Miao
    Tabea Moll
    Tian Tian
    Zhi Wei
    Sanna Madan
    Ryan J. Sullivan
    Genevieve Boland
    Keith Flaherty
    Meenhard Herlyn
    Eytan Ruppin
    Nature Medicine, 2018, 24 : 1545 - 1549
  • [37] Long-Term Outcomes of Immune Checkpoint Inhibition in Metastatic Melanoma
    Aroldi, Francesca
    Middleton, Mark R.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2022, 23 (03) : 331 - 338
  • [38] Primary resistance to immune-checkpoint inhibitors in patients with metastatic melanoma
    Amaral, Teresa
    Assi, Zeinab
    Keim, Ulrike
    Meiwes, Andreas
    Thomas, Ioannis
    Wilhelmi, Julia
    Eigentler, Thomas
    Garbe, Claus
    Seeber, Olivia
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18
  • [39] Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis
    Yamada, Kayoko
    Takeuchi, Masaki
    Fukumoto, Takeshi
    Suzuki, Minako
    Kato, Ai
    Mizuki, Yuki
    Yamada, Norihiro
    Kaneko, Takeshi
    Mizuki, Nobuhisa
    Horita, Nobuyuki
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [40] Thyroiditis in an Adolescent Treated with Immune Checkpoint Inhibitors for Metastatic Ocular Melanoma
    Reynolds, Sarah
    Larson, Noelle
    HORMONE RESEARCH IN PAEDIATRICS, 2021, 94 (SUPPL 2): : 125 - 125